"Mount Sinai To Deploy New Supercomputer, Integrating Genomic And Clinical Data"
Mount Sinai Health System said today its researchers will be able to explore more complex scientific questions more quickly once the New York City health system builds its second “Big Omics Data Engine” (BODE 2) supercomputer, to be funded through a $2 million grant awarded by the U.S. Department of Health and Human Services. Through BODE 2, Mount Sinai said, its researchers will be able to use machine learning approaches to mine deep databases of genomic and clinical information, with precision medicine in mind. “With BODE 2, we are renewing our commitment to push the boundaries of scientific research, tackle questions that we did not previously have the computational power to take on, and achieve breakthroughs that transform clinical care worldwide,” said Dennis Charney, MD, the Anne and Joel Ehrenkranz Dean of the Icahn School of Medicine at Mount Sinai and president of academic affairs for the Mount Sinai Health System. “This new supercomputer will enable us to mine deep databases of genomic and clinical information using machine-learning approaches to propel the personalized medicine of today into better medicine tomorrow,” said Eimear Kenny, PhD, associate professor of medicine, general internal medicine, and genetics and genomic Sciences, at the Icahn School of Medicine at Mount Sinai and principal investigator of the TOPMed Program. “Computing capability of this size and speed is not available widely, and Mount Sinai’s investment in building this infrastructure will translate into more robust genetics and population analysis, gene expression, machine learning, and structural and chemical biology investigations, and result in new insights and advances in a wide range of diseases including Alzheimer’s, autism, influenza, prostate cancer, schizophrenia, and substance use disorders,” said Patricia Kovatch, BS, associate professor of genetics and genomic sciences, pharmacological sciences at the Icahn School of Medicine at Mount Sinai.
— Dennis S. Charney, MD, Anne and Joel Ehrenkranz Dean, Icahn School of Medicine at Mount Sinai, President, Academic Affairs, Mount Sinai Health System
— Eimear E. Kenny, PhD, Associate Professor, Medicine, General Internal Medicine, Genetics and Genomic Sciences, Founding Director, Center for Genomic Health, Icahn School of Medicine at Mount Sinai
— Patricia Kovatch, BS, Associate Professor, Genetics and Genomic Sciences, Pharmacological Sciences, Senior Associate Dean, Scientific Computing and Data Science, Icahn School of Medicine at Mount Sinai